CD28 and neoplasm: CD8+ Treg, in particular those expressing the CD8+CD28-CD127lowCD39+ phenotype, are regulatory T lymphocytes found highly concentrated within tumor microenvironment, where they can exert remarkable immunosuppressive activity due to their capacity to target T cell proliferation and cytotoxicity (19–21).